Custom synthesis | Naphthyridine | Pyrimidine | Indoline |
CardioCerebral-Vasculars

Voglibose 83480-29-9

Voglibose 83480-29-9

Voglibose (INN and USAN, trade name Voglib, marketed by Mascot Health Series) is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with diabetes mellitus. Voglibose delays the absorption of glucose thereby reducing the risk of macrovascular complications. Voglibose is a research product of Takeda Pharmaceutical Company, Japan's largest pharmaceutical company. Voglibose was first launched in 1994, under the trade name BASEN, to improve postprandial hyperglycemia in diabetes mellitus.

GMP for Voglibose 83480-29-9 is available.
 
Disclaimer:Those products (Voglibose 83480-29-9) patented are for lab analytical & research purposes only.